作者：
Britten,C.M. [1]
;
Janetzki,S. [2]
;
VanDerBurg,S.H. [3]
;
Huber,C. [4]
;
Kalos,M. [5]
;
Levitsky,H.I. [6]
;
Maecker,H.T. [7]
;
Melief,C.J.M. [8]
;
O'Donnell-Tormey,J. [9]
;
Odunsi,K. [10]
;
Old,L.J. [11]
;
Pawelec,G. [12]
;
Roep,B.O. [13]
;
Romero,P. [14]
;
Hoos,A. [15]
;
Davis,M.M.
作者单位：
Department of Microbiology and Immunology, Institute for Immunity, Transplantation and Infection
[1]
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore
[2]
ZellNet Consulting, Inc., Fort Lee, NJ, United States
[3]
Center for Medical Research, University of Tübingen, Clinical School Tübingen, Tübingen, Germany
[4]
Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford
[5]
Department of Immunhaematology, Leiden University, Medical Center, Leiden, Netherlands
[6]
Department of Gynecologic Oncology, Roswell Park Cancer Center, Buffalo, NY, United States
[7]
Department of Clinical Oncology, Leiden University, Medical Center, Leiden, Netherlands
[8]
Association for Cancer Immunotherapy (CIMT), Mainz, Germany
[9]
III. Medical Department, Johannes Gutenberg-University, Mainz, Germany, Clinical Development
[10]
Translational and Correlative Studies Laboratory, University of Pennsylvania, School of Medicine
[11]
Bristol-Myers Squibb, Wallingford, CT, United States
[12]
Laboratory of Human Cancer Immunology, Ludwig Institute for Cancer Research, MSKCC, New York, NY
[13]
Cancer Research Institute, New York, NY, United States
[14]
Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital
[15]
发布时间
2013-11-20
换一批
